2m 2m 2m 2m 2m 2m 2m
Exozymes (EXOZ)
NASDAQ
$6.48+$0.17 (+2.75%)
Price as of Sep 11, 2026 7:30 PM EDT- $58.5MMarket Cap
- -49.18%1-Year Change
- BiotechnologyIndustry
Exozymes (EXOZ)
$6.48+$0.17 (+2.75%)
EXOZ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.30 | ||
Change | +$0.13 (+2.13%) | ||
Open | $6.09 | ||
High | $6.65 | ||
Low | $6.09 | ||
Previous Close | $6.17 | ||
Volume | 4,558 | ||
30-Day Average Volume | 5,391 | ||
1-Week Change | -8.01% | ||
1-Month Change | 9.40% | ||
1-Year Change | -49.18% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 9.3M | ||
Total Assets | $8.0M | ||
Market Cap | $58.5M | ||
Enterprise Value | $52.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.6M | ||
EBIT | $0.00 | ||
EBITDA | $76,949.00 | ||
Net Working Capital | $4.6M | ||
EPS | -$0.33 | ||
Enterprise Value/EBITDA | 687 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 16 | ||
P/E | -19 | ||
PEG | 1 | ||
Price/Free Cash Flow | -36 | ||
Price/Operating Cash Flow | -36 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue